SCHEMBL6709911

SCHEMBL6709911

Cc1cc(CC(=O)Nc2cccc3cc(C(=O)Nc4ccc(Br)cc4-c4nnn[nH]4)[nH]c23)on1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
GPR35 Q9HC97 4/20 0.35
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
MAP3K5 Q99683 1/20 0.34
LMNA P02545 3/20 0.33
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPT P10636 2/20 0.33
NPC1 O15118 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
POLB P06746 2/20 0.33
NSD2 O96028 1/20 0.33
VHL P40337 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713272 0.91 PTK2B (0.35) HDAC3HDAC1MAP3K5LMNAMEN1
SCHEMBL6707676 0.89 ALDH1A1 (0.36) HDAC3HDAC1MAP3K5LMNAMAPT
SCHEMBL6914610 0.88 GRIK1 (0.37) HIF1ANPSR1RXFP1GPR35HDAC3
SCHEMBL6709051 0.86 PARP14 (0.41) HIF1ANPSR1RXFP1GPR35MAP3K5
SCHEMBL6710241 0.86 GPR35 (0.43) HIF1ANPSR1RXFP1GPR35MAP3K5
SCHEMBL6710064 0.85 ALDH1A1 (0.40) HIF1ANPSR1RXFP1GPR35HDAC3
SCHEMBL6710448 0.85 GPR35 (0.38) HIF1ANPSR1RXFP1GPR35MAP3K5
SCHEMBL6710320 0.85 PARP14 (0.39) HIF1ANPSR1RXFP1GPR35LMNA
SCHEMBL6711411 0.85 GPR35 (0.42) HIF1ANPSR1RXFP1GPR35HDAC3
SCHEMBL6712420 0.84 PARP14 (0.38) HIF1ANPSR1RXFP1GPR35HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 HIF1A 296/4885NPSR1 2999/4885RXFP1 3836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.